Shares of Johnson & Johnson JNJ, -2.03% shed 2.03% to $168.72 Tuesday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index SPX, -0.72% falling 0.72% to 4,170.70 and Dow Jones Industrial Average DJIA, -0.48% falling 0.56% to 32,632.64. The stock’s fall snapped a four-day winning streak. Johnson & Johnson closed $11.20 below its 52-week high ($179.92), which the company reached on August 20th.
The stock demonstrated a mixed performance when compared to some of its competitors Tuesday, as Roche Holding AG Part. Cert. RHHVF, -3.82% fell 3.82% to $365.50, Merck & Co. Inc. MRK, -1.00% fell 1.00% to $76.95, and Pfizer Inc. PFE, -1.13% fell 1.13% to $47.44. Trading volume (11.0 M) eclipsed its 50-day average volume of 7.7 M.